36
Participants
Start Date
March 9, 2016
Primary Completion Date
January 28, 2020
Study Completion Date
January 28, 2020
Abatacept
Abatacept IV administered on Day 1, 15, 29 and then every 28 days
Normal Saline
Normal Saline administer on Day 1, 15, 29 and then every 28 days
D5W
Dextrose 5% in Water (D5W) administered on Day 1, 15, 29 and then every 28 days
New York University Langone Medical Center, New York
Columbia University Medical Center (Cumc), New York
Local Institution, Pittsburgh
University Of Pennsylvania, Philadelphia
Children's National Health System, Washington D.C.
NIH Clinical Center - NIDDK, Bethesda
Duke University, Durham
Levine Children's Hospital, Charlotte
Nemours Childrens Hospital, Orlando
University Of Miami Miller School Of Medicine, Miami
The University Of Alabama At Birmingham, Birmingham
University of Alabama-Birmingham-Parent Account, Birmingham
The Ohio State University Wexner Medical Center, Columbus
The Metro Health System, Cleveland
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Mayo Clinic, Rochester
Loyola University Medical Center, Maywood
Childrens Mercy Hospital, Kansas City
Renal Disease Research Institute, Dallas
University Of Texas Southwestern Medical Center, Dallas
University Of Colorado Denver, Aurora
Los Angeles Biomedical Research Institute, Torrance
Emory University, Atlanta
Boston Childrens Hospital, Boston
Brigham And Women'S Hosp Inc., Boston
Cincinnati Children'S Hospital Medical Center, Cincinnati
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY